The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints

Hepatocellular carcinoma (HCC) is a challenging malignancy characterised by clinical and biological heterogeneity, independent of the stage. Despite the application of surveillance programs, a substantial proportion of patients are diagnosed at advanced stages when curative treatments are no longer...

Descripción completa

Detalles Bibliográficos
Autores principales: Giuffrida, Paolo, Celsa, Ciro, Antonucci, Michela, Peri, Marta, Grassini, Maria Vittoria, Rancatore, Gabriele, Giacchetto, Carmelo Marco, Cannella, Roberto, Incorvaia, Lorena, Corsini, Lidia Rita, Morana, Piera, La Mantia, Claudia, Badalamenti, Giuseppe, Brancatelli, Giuseppe, Cammà, Calogero, Cabibbo, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687474/
https://www.ncbi.nlm.nih.gov/pubmed/36359347
http://dx.doi.org/10.3390/biomedicines10112827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687474/
https://www.ncbi.nlm.nih.gov/pubmed/36359347
http://dx.doi.org/10.3390/biomedicines10112827

Ejemplares similares